Plasma levels of matrix metalloproteinase‐9 (MMP‐9) are associated with cognitive performance in patients with schizophrenia

Plasma levels of matrix metalloproteinase‐9 (MMP‐9) are associated with cognitive performance in patients with schizophrenia

Abstract Aim Matrix metalloproteinase‐9 (MMP‐9) has been shown to modulate synaptic plasticity and may contribute to the pathophysiology of schizophrenia. This study investigated the peripheral levels of MMP‐9 and its association with cognitive functions in patients with schizophrenia to see the pos...

Full description

Bibliographic Details
Main Authors: Noriko Kudo, Hidenaga Yamamori, Tamaki Ishima, Kiyotaka Nemoto, Yuka Yasuda, Michiko Fujimoto, Hirotsugu Azechi, Tomihisa Niitsu, Shusuke Numata, Manabu Ikeda, Masaomi Iyo, Tetsuro Ohmori, Masaki Fukunaga, Yoshiyuki Watanabe, Kenji Hashimoto, Ryota Hashimoto
Format: Article
Language:English
Published: Wiley 2020-06-01
Series:Neuropsychopharmacology Reports
Subjects:
cognitive performance
matrix metalloproteinase‐9
schizophrenia
Wechsler Adult Intelligence Scale
Wechsler Memory Scale
Online Access:https://doi.org/10.1002/npr2.12098

Internet

https://doi.org/10.1002/npr2.12098

Similar Items